Clarient Inc: Company Report
31 Columbia
Aliso Viejo CA 92656
http://www.clarientinc.com/ - Phone: 949-4255700
- Fax: 949-4255701
- Industry : Medical Laboratories & Research
- Employees : 326
- Exchange : NASDAQ
Clarient, Inc. (Clarient) is an oncology diagnostics services company. The Company delivers oncology diagnostic testing services to community pathologists, biopharmaceutical companies, and researchers. As of December 31, 2008, all of the Company's services were provided within the United States, and substantially all of the Company's assets were located within the United States. The Company provides a range of cancer diagnostic and consultative services, which includes technical laboratory services and professional interpretation; such reports and analyses are provided through its Internet-based application, PATHSiTE. Clarient’s technologies used to assess and characterize cancer include immunohistochemistry (IHC), flow cytometry, molecular/PCR, fluorescent in situ hybridization (FISH), cytogenetics, and histology.
| Stock Activity |
|---|
|
Last Price |
2.36 |
|
52 Week High |
4.43 |
|
52 Week Low |
0.90 |
|
Volume |
213,216 |
|
Average Daily Volume (13wk) |
843,019 |
|
50 Day Moving Average |
3.43 |
|
200 Day Moving Average |
3.06 |
|
Volatility (beta) |
0.78 |
| Stock Price History |
|---|
| | Change | Relative Strength |
|---|
| fyi |
Last 3 Months |
-31.0% |
10 |
|
Last 6 Months |
-9.4% |
23 |
| fyi |
Last 12 Months |
152.6% |
85 |
Historical charts
| Institutional Statistics |
|---|
| Analyst Consensus | Moderate Buy | | fyi | Institutional Ownership | 36.80% |
More Analyst Ratings
Want to learn how to evaluate a stock? Walk through the steps using the Research Wizard. | advertisement
| Financials |
|---|
| | Last 12 Months | 5 Year Growth |
|---|
|
Sales |
90.3 Mil |
44.0% |
|
Income |
-11.4 Mil |
NA |
|
Dividend Rate |
0.00 |
NA |
|
Dividend Yield |
0.00% |
0.00% |
More financials
| Fundamental Data |
|---|
| Debt/Equity Ratio | NA | | Gross Margin | 54.06% | | Net Profit Margin | -7.84% | | Total Shares Outstanding | 77.7 Mil | | Market Capitalization | 183.30 Mil | | Earnings/Share | -0.13 |
More financial ratios
| Earnings Estimates
|
|---|
| Qtr(12/09) EPS Estimate |
0.01 |
| FY(12/09) EPS Estimate |
-0.02 |
| Current P/E |
NA |
| FY(12/10) EPS Estimate |
0.12 |
| Forward P/E |
19.67 |
| Next Earnings Release:
N/A | | More analyst estimates
|
Recent News